Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 873 of 1,261
  1. US 8435979

    Use of imipramine blue and analogs thereof in treating cancers

    The United States of America as Represented by the Dept. of Veterans Affairs · Granted May 7, 2013 · Expires May 2, 2033

    granted
  2. US 8435995

    Pyridazinone compounds

    Takeda Pharmaceutical Company Limited · Granted May 7, 2013 · Expires May 2, 2033

    granted
  3. US 8435941

    Mini-hepcidin peptides and methods of using thereof

    The Regents of the University of California · Granted May 7, 2013 · Expires May 2, 2033

    granted
  4. US 8435575

    Use of gingerols for cancer patients suffering from nausea and emesis induced by chemotherapy

    Aphios Corporation · Granted May 7, 2013 · Expires May 2, 2033

    granted
  5. US 8435533

    Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia

    The Board of Regents of the University of Texas System · Granted May 7, 2013 · Expires May 2, 2033

    granted
  6. US 8436224

    Methods for testing for caloric restriction (CR) mimetics

    BioMarker Pharmaceuticals, Inc. · Granted May 7, 2013 · Expires May 2, 2033

    granted
  7. US 8435570

    Nitrite formulations and their use as nitric oxide prodrugs

    The Board of Regents of the University of Texas System · Granted May 7, 2013 · Expires May 2, 2033

    granted
  8. US 8435505

    Pharmaceutical compositions and methods for delivering such compositions

    Nektar Therapeutics · Granted May 7, 2013 · Expires May 2, 2033

    granted
  9. US 8435497

    Formoterol of and ciclesonide combination

    TAKEDA GMBH · Granted May 7, 2013 · Expires May 2, 2033

    granted
  10. US 8436043

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 7, 2013 · Expires May 2, 2033

    granted
  11. US 8436014

    Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted May 7, 2013 · Expires May 2, 2033

    granted
  12. US 8436154

    Crystallizing method of erythromycin

    SUNSHINE LAKE PHARMA CO., LTD. · Granted May 7, 2013 · Expires May 2, 2033

    granted
  13. US 8435960

    Devices for improved wound management

    Lakewood Amedex, Inc. · Granted May 7, 2013 · Expires May 2, 2033

    granted
  14. US 8436200

    Process for making (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-flouro-4- iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione and intermediates thereof

    Takeda Pharmaceutical Company Limited · Granted May 7, 2013 · Expires May 2, 2033

    granted
  15. US 8435504

    Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid

    Nektar Therapeutics · Granted May 7, 2013 · Expires May 2, 2033

    granted
  16. AU 2012205809

    Phenethylsulfone isoindoline derivatives as inhibitors of PDE 4 and/or cytokines

    CELGENE CORP [CH] · Granted May 2, 2013 · Expires Apr 27, 2033

    granted
  17. US 8431124

    Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP)

    HALOZYME, INC. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted
  18. US 8430832

    Selective cytopheresis devices and related methods thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted
  19. US 8431176

    Liquid chromatographic fraction of enzymatically polymerized flavonoid as an antioxidant

    The United States of America as represented by the Secretary of the Army · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted
  20. US 8431543

    Chitosan based polymer conjugate and a method for producing the same

    ENGENE, INC. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted
  21. US 8431570

    Methods of utilizing arylpiperazine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted
  22. US 8431626

    Disulfide monomers comprising ethylenically unsaturated norbornyl groups suitable for dental compositions

    The Regents of the University of Colorado · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted
  23. US 8431594

    Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted
  24. US 8431690

    T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.